Literature DB >> 21593563

Peripheral oxidative stress biomarkers in mild cognitive impairment and Alzheimer's disease.

Larissa Lobo Torres1, Nathalia Barbosa Quaglio, Gisele Tavares de Souza, Raphael Tamborelli Garcia, Lívia Mendonça Munhoz Dati, Wallace Luiz Moreira, Ana Paula de Melo Loureiro, Juliana Nery de Souza-Talarico, Jerusa Smid, Cláudia Selito Porto, Cássio Machado de Campos Bottino, Ricardo Nitrini, Silvia Berlanga de Moraes Barros, Rosana Camarini, Tania Marcourakis.   

Abstract

Oxidative stress has been associated with normal aging and Alzheimer's disease (AD). However, little is known about oxidative stress in mild cognitive impairment (MCI) patients who present a high risk for developing AD. The aim of this study was to investigate plasma production of the lipid peroxidation marker, malonaldehyde (MDA) and to determine, in erythrocytes, the enzymatic antioxidant activity of catalase, glutathione peroxidase (GPx), glutathione reductase (GR), and glutathione S-transferase (GST) in 33 individuals with MCI, 29 with mild probable AD and 26 healthy aged subjects. GR/GPx activity ratio was calculated to better assess antioxidant defenses. The relationship between oxidative stress and cognitive performance was also evaluated by the Mini Mental State Examination (MMSE). AD patients showed higher MDA levels than both MCI and healthy elderly subjects. MCI subjects also exhibited higher MDA levels compared to controls. Catalase and GPx activity were similar in MCI and healthy individuals but higher in AD. GR activity was lower in MCI and AD patients than in healthy aged subjects. Additionally, GR/GPx ratio was higher in healthy aged subjects, intermediate in MCI and lower in AD patients. No differences in GST activity were detected among the groups. MMSE was negatively associated with MDA levels (r = -0.31, p = 0.028) and positively correlated with GR/GPx ratio in AD patients (r = 0.68, p < 0.001). MDA levels were also negatively correlated to GR/GPx ratio (r = -0.31, p = 0.029) in the AD group. These results suggest that high lipid peroxidation and decreased antioxidant defenses may be present early in cognitive disorders.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21593563     DOI: 10.3233/JAD-2011-110284

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  74 in total

1.  The effect of antioxidant vitamins E and C on cognitive performance of the elderly with mild cognitive impairment in Isfahan, Iran: a double-blind, randomized, placebo-controlled trial.

Authors:  A M Alavi Naeini; I Elmadfa; A Djazayery; M Barekatain; M R Aghaye Ghazvini; M Djalali; A Feizi
Journal:  Eur J Nutr       Date:  2013-12-11       Impact factor: 5.614

Review 2.  Cognitive impairment, genomic instability and trace elements.

Authors:  A Meramat; N F Rajab; S Shahar; R Sharif
Journal:  J Nutr Health Aging       Date:  2015-01       Impact factor: 4.075

3.  Effects of Brazil nut consumption on selenium status and cognitive performance in older adults with mild cognitive impairment: a randomized controlled pilot trial.

Authors:  Bárbara Rita Cardoso; Daniel Apolinário; Verônica da Silva Bandeira; Alexandre Leopold Busse; Regina Miksian Magaldi; Wilson Jacob-Filho; Silvia Maria Franciscato Cozzolino
Journal:  Eur J Nutr       Date:  2015-01-08       Impact factor: 5.614

4.  GSTM1 Null Genotype and GSTP1 Ile105Val Polymorphism Are Associated with Alzheimer's Disease: a Meta-Analysis.

Authors:  Mo Wang; Yu Li; Lulu Lin; Guijun Song; Teng Deng
Journal:  Mol Neurobiol       Date:  2015-01-30       Impact factor: 5.590

Review 5.  Peripheral mitochondrial dysfunction in Alzheimer's disease: focus on lymphocytes.

Authors:  Kristina Leuner; Kathrin Schulz; Tanja Schütt; Johannes Pantel; David Prvulovic; Virginie Rhein; Egemen Savaskan; Christian Czech; Anne Eckert; Walter E Müller
Journal:  Mol Neurobiol       Date:  2012-07-22       Impact factor: 5.590

Review 6.  BioAge: toward a multi-determined, mechanistic account of cognitive aging.

Authors:  Correne A DeCarlo; Holly A Tuokko; Dorothy Williams; Roger A Dixon; Stuart W S MacDonald
Journal:  Ageing Res Rev       Date:  2014-09-30       Impact factor: 10.895

7.  Can urinary excretion rate of 8-isoprostrane and malonaldehyde predict postoperative cognitive dysfunction in aging?

Authors:  Qinghao Cheng; Jiawan Wang; Anshi Wu; Rujin Zhang; Lei Li; Yun Yue
Journal:  Neurol Sci       Date:  2013-02-05       Impact factor: 3.307

Review 8.  Zinc and its effects on oxidative stress in Alzheimer's disease.

Authors:  Ye Yuan; Fenglan Niu; Ya Liu; Na Lu
Journal:  Neurol Sci       Date:  2014-02-13       Impact factor: 3.307

Review 9.  "Boomerang Neuropathology" of Late-Onset Alzheimer's Disease is Shrouded in Harmful "BDDS": Breathing, Diet, Drinking, and Sleep During Aging.

Authors:  Mak Adam Daulatzai
Journal:  Neurotox Res       Date:  2015-04-25       Impact factor: 3.911

Review 10.  Mitochondrial abnormalities in Alzheimer's disease: possible targets for therapeutic intervention.

Authors:  Diana F Silva; J Eva Selfridge; Jianghua Lu; Lezi E; Sandra M Cardoso; Russell H Swerdlow
Journal:  Adv Pharmacol       Date:  2012
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.